The European Centre for Disease Prevention and Control (ECDC) reports that chronic diseases account for over 80% of healthcare burden in Europe, while multiple EU countries have expanded reimbursement frameworks, improving access to innovative therapies like GLP-1 receptor agonists
Tirzepatide Tirzepatide is a dual GIP and GLP-1 receptor agonist used to treat type II diabetes in adults as an adjunct to diet and exercise
Additionally, these patients experienced a significant reduction in major cardiovascular events, such as heart attacks and strokes
It represents a fascinating avenue of study for tissue repair and regeneration
The SubMagna sublingual drops are placed under the tongue and absorbed through the mucous membranes, offering a needle-free option but with less established pharmacokinetic data
Instead, it's about supporting metabolic health, reducing cardiometabolic risk factors, and helping people stay healthier as they age